Could a simple blood test spot Alzheimer’s decades before symptoms?

Science · Published 8 October 2026 Swipe more like this →

In short: Alzheimer’s disease begins in the brain long before the first sign of forgetfulness. While traditional diagnosis relies on invasive spinal taps or expensive scans, new research into circular RNAs and CRISPR technology suggests we might soon identify these silent neurological changes through a routine blood draw.

The primary challenge in treating Alzheimer’s disease (AD) is its timeline: pathological changes occur decades before cognitive decline begins. Current gold-standard diagnostics often require cerebrospinal fluid collection via lumbar puncture or expensive amyloid-positron emission tomography (PET). However, researchers are pivoting toward blood-based biomarkers to make early detection more accessible and less invasive.

One promising avenue involves circular RNAs (circRNAs)—single-stranded RNA molecules that form covalently closed loops. Because of their unique structure, circRNAs are twice as stable as linear transcripts and possess the ability to cross the blood–brain barrier. A predictive model using 34 specific blood circRNAs has shown the ability to predict progression to symptomatic AD, even outperforming established markers like pTau217 and amyloid-PET in large cohorts.

Another breakthrough involves using CRISPR technology for rapid detection. Scientists at the University of Connecticut developed a test using the Cas13A protein, which acts like molecular scissors to snip RNA. When the protein encounters specific Alzheimer’s-associated microRNA biomarkers in blood plasma, it triggers a chemical reaction that causes dye molecules to glow. This method could potentially allow for fast, low-cost screening directly in a doctor's office.

These advancements are critical because mortality increases with disease severity. By identifying AD pathology in cognitively unimpaired individuals—potentially up to 20 years before symptoms manifest—clinicians may be able to initiate interventions that delay or prevent irreversible neurodegeneration.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Could we detect Alzheimer's disease decades before symptoms appear?
• Why targeting a single protein hasn't cured Alzheimer’s disease
• Could a temporary lack of blood flow trigger Alzheimer's disease?
• Alzheimer's drug trials have failed 99.5% of the time
• Soluble amyloid-β and tau may jointly drive Alzheimer's before plaques form
• Is the constant hum of electromagnetic fields from your devices actually dangerous?
• Can we finally develop a universal flu vaccine that targets every single strain?
• Is music just a secret form of counting happening inside your head?
• Is the science of human cloning and designer babies actually possible today?
• Can we identify wildlife simply by vacuuming the air?
• Is time a fundamental reality or a trick of the brain?
• Why you must add back what you subtracted in set theory

More in Science · Latest · A–Z · All topics